Strategic Blueprint’s Labcorp LH Stock Holding History

Strategic Blueprint’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-92	Closed	-$22K	–	911
2021 Q2	$22K	Buy	+92	New	+$21K	﹤0.01%	796

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

MCM

Melvin Capital Management New York $9.86B AUM 16.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Strategic Blueprint's LH Position: Q3 2021 in Review

Strategic Blueprint sold out of Labcorp (LH) in Q3 2021, closing a stake of 92 shares — an estimated $22K sold.

Strategic Blueprint first reported a position in LH in Q2 2021 and held it in 1 quarter. The position peaked at $22K in Q2 2021. 992 funds tracked by Wall St. Rank hold LH as of Q3 2021.

Strategic Blueprint reported no remaining Labcorp position as of Q3 2021 after selling out during the quarter.
Strategic Blueprint sold 92 Labcorp shares in Q3 2021, an estimated $22K.
Strategic Blueprint first reported a position in Labcorp in Q2 2021 and held it in 1 quarter.
Strategic Blueprint's Labcorp position peaked at $22K in Q2 2021.
992 funds tracked by Wall St. Rank held Labcorp as of Q3 2021.

Based on Strategic Blueprint's 13F filing for Q3 2021, filed 12 Nov 2021.